SOPHiA GENETICS SA
corporate_fare Company Profile
SOPHiA GENETICS SA (NASDAQ:SOPH) is a publicly traded company in the Technology sector. Wiseek monitors SOPH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- SOPHiA GENETICS and Memorial Sloan Kettering to form precision oncology joint venture
- SOPHiA GENETICS & Memorial Sloan Kettering Form Joint Venture for Precision Oncology Hub
- SOPHiA GENETICS Announces CEO Transition, Reports 2025 Losses, and Proposes Share Capital Increase
- SOPHiA GENETICS Reports Q1 Revenue Growth, Reaffirms FY26 Guidance, and Secures $14.5M via ATM Offering
- SOPHiA GENETICS Reports 19% Revenue Growth, Secures $25M Loan, Wins Key Patent Ruling
Financial Snapshot
Insider Transactions
SOPH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.